Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Crixivan price break for uninsured patients negotiated by AIDS groups and Stadtlanders.

Executive Summary

MERCK CRIXIVAN OFFERED AT 19.5% PRICE BREAK TO CASH-PAYING CUSTOMERS through Community Prescription Service. Beginning April 18, for an annual fee of $18 to CPS, patients without insurance will be able to get Crixivan (indinavir) for AWP minus 12% plus a $2 dispensing fee, or $398 for a month's supply. AWP is listed at $450 for 200 mg 360's and 400 mg 180's by Medi-Span. The recommended dose is 800 mg every eight hours.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel